CTTI Program to Increase Adoption of Mobile Clinical Trials
CTTI is excited to introduce its Mobile Clinical Trials (MCT) Program, which will identify and address challenges to the use of mobile technologies to facilitate clinical trials for regulatory submissions. These technologies have the potential to increase the quality and efficiency of clinical trials by allowing remote participation and monitoring, creating opportunities to develop novel endpoints, and streamlining data collection.
The integration of mobile technologies into clinical trials is in the early phases. Through the MCT Program, CTTI will help create a pathway to drive this promising transformation.
CTTI’s MCT Program includes four projects addressing specific challenges. Within each of these areas, CTTI’s multi-stakeholder teams have begun gathering evidence to develop tools and best practices that can be deployed throughout the clinical trials enterprise to promote widespread integration of mobile technologies.
Learn more about the CTTI MCT projects:
- Legal and Regulatory Issues
- Novel Endpoints
- Stakeholder Perceptions
- Use of Mobile Devices
CTTI will present on this new initiative at the Mobile in Clinical Trials Conference on Monday, September 19, 2016.